CoSyne Therapeutics
Louwai Muhammed is the Chief Executive Officer and Co-Founder of CoSyne Therapeutics. They have a background in neurology, having worked as a Neurology Registrar at NHS. They also have experience as a Core Medical Doctor and Academic Foundation Doctor. Louwai Muhammed holds a Master's Degree from Harvard University and a BM BCh in Medicine from the University of Oxford. Additionally, they have a MA in Medicine (Neuroscience) from the University of Cambridge and a degree in Neuroscience and Technology from Massachusetts Institute of Technology. Their educational journey began at The Coopers' Company and Coborn School where they completed their A2 Level.
This person is not in any offices
CoSyne Therapeutics
CoSyne Therapeutics is a vertically integrated AI Drug Discovery company aiming to bring speed to precision medicine through polymathic AI to help patients with under-served diseases of the brain.